Наука
Плаштеви невидљивости, синтетичка биологија, фанки хемија и еволуција научне мисли—ова страница покрива трендове и вести које ће водити будућност науке.
256465
Сигнали
https://www.nature.com/articles/s41598-024-59884-w?code=dcc221e3-6d58-4623-8de1-f3e402b3b9d2&error=cookies_not_supported
Сигнали
Природа
Goodpaster, B. H. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 1059-1064. https://doi.org/10.1093/gerona/61.10.1059 (2006).Article
ЦроссРеф
Гоогле Сцхолар
Janssen, I.,...
ЦроссРеф
Гоогле Сцхолар
Janssen, I.,...
256466
Сигнали
https://www.foxnews.com/health/cancer-trends-revealed-including-common-types-disease-and-biggest-risk-factors
Сигнали
Фокневс
Dr. Marc Siegel reacts to what is behind rising cancer cases among young adults and advises to eat a healthy diet, cut back on alcohol consumption, and get the HPV vaccine Almost 40% of Americans will receive a cancer diagnosis at some point in their lifetime — but certain types are more common...
256467
Сигнали
https://twistedsifter.com/2024/04/could-alzheimers-spread-through-blood-transfusions-new-research-suggests-a-link/
Сигнали
Твистедсифтер
Alzheimer's has one of the biggest research funds of any disease out there, and for good reason. It affects many, and is devastating not only for the people suffering from it, but those who love them. Now, scientists are finding evidence that it could be spread through a simple blood transfusion. Researchers have suspected for a long time that more than genetic factors are at play.
256469
Сигнали
https://www.medpagetoday.com/podcasts/healthwatch/109958
Сигнали
Медпагетодаи
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso, look at the top medical stories of the week.
This week's...
This week's...
256491
Сигнали
https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-fasenra-copd-approval/
Сигнали
Фармацеутска-технологија
AstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically for the eosinophilic phenotype, in children aged 6-11 years in more than 80 countries, including the US, EU, and Japan.
Fasenra is a monoclonal antibody that inhibits the alpha subunit of the...
Fasenra is a monoclonal antibody that inhibits the alpha subunit of the...
ФУТУРЕ ТИМЕЛИНЕ
256490
Сигнали
https://www.beingpatient.com/what-are-biologics-for-alzheimers/
Сигнали
Бити стрпљив
Ако сматрате да су наши чланци и интервјуи корисни, размислите о томе да постанете члан наше заједнице као подршка. Фрустрирани недостатком уреднички независног извора информација о здрављу мозга и Алцхајмеровој болести, одлучили смо да направимо Беинг Патиент. Ми смо тим посвећених новинара који покривају најновија истраживања о Алцхајмеру, доносећи вам приступ стручњацима и подижући перспективу пацијената о томе како је живети са деменцијом.
ФУТУРЕ ТИМЕЛИНЕ
256489
Сигнали
https://time.com/6972086/ozempic-anti-inflammatory-drug/
Сигнали
Време
Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history. The file included descriptions of her initial diagnosis of Crohn's disease as a teenager, the multiple...
ФУТУРЕ ТИМЕЛИНЕ
256488
Сигнали
https://www.nature.com/articles/d41586-024-01215-0?code=49a116c5-eeb3-4ba2-8fd0-34d9c9e00371&error=cookies_not_supported
Сигнали
Природа
US drug regulators dropped a bombshell in November 2023 when they announced an investigation into one of the most celebrated cancer treatments to emerge in decades. The US Food and Drug Administration (FDA) said it was looking at whether a strategy that involves engineering a person's immune cells to kill cancer was leading to new malignancies in people who had been treated with it.
ФУТУРЕ ТИМЕЛИНЕ
256487
Сигнали
https://www.finsmes.com/2024/04/surf-bio-receives-1-6m-non-dilutive-grant-from-bill-melinda-gates-foundation.html
Сигнали
Финсмес
Surf Bio Receives $1.6M Non-Dilutive Grant From Bill & Melinda Gates Foundation
Surf Bio, a Palo Alto, CA-based biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6M grant from the Bill & Melinda Gates Foundation.
Компанија намерава да...
Surf Bio, a Palo Alto, CA-based biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6M grant from the Bill & Melinda Gates Foundation.
Компанија намерава да...
ФУТУРЕ ТИМЕЛИНЕ
256486
Сигнали
https://www.finsmes.com/2024/04/enlaza-therapeutics-raises-100m-in-series-a-financing.html
Сигнали
Финсмес
Enlaza Therapeutics, a La Jolla, CA-based covalent biologic platform company, raised $100M in Series A funding.
The round was led by Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors Frazier Life Sciences, Avalon Ventures,...
The round was led by Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors Frazier Life Sciences, Avalon Ventures,...
ФУТУРЕ ТИМЕЛИНЕ
256485
Сигнали
https://www.statnews.com/2024/04/30/economics-holding-back-promise-antibody-therapies-infectious-diseases/
Сигнали
Статневс
Next-generation broadly neutralizing antibodies (bnAbs) have the potential to transform the fight against global health threats like HIV, malaria, and Ebola. The commercialization of these innovative antibody therapies could save millions of lives annually. But turning promise into reality...
256468
Сигнали
https://www.cnbc.com/2024/05/05/within-a-few-years-generative-ai-will-design-new-drugs-on-its-own.html
Сигнали
ЦНБЦ
The advances related to AI are taking place within a field of biology that has been increasingly digitized at what Powell describes as "unprecedented scales and resolutions." It's a medical revolution that includes spatial genomics scanning millions of cells within tissue, in 3-and AI model-building that specifically benefits from a catalog of chemicals already in a digital form which allows generative AI transformer models to now go to work on them.
256484
Сигнали
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-announces-promising-findings-in-phase-2b3-clinical-trial-of-nrx-101-vs-lurasidone-for-treatment-of-suicidal-bipolar-depression-302131482.html
Сигнали
Прневсвире
NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia relative to lurasidone - never previously shown with an oral antidepressant. Suicidality signal met the...
256483
Сигнали
https://www.fda.gov/news-events/press-announcements/fda-roundup-april-30-2024
Сигнали
ФДА
За објављивање одмах:
Април КСНУМКС, КСНУМКС
Данас, америчка администрација за храну и лекове пружа кратак преглед вести из целе агенције:
Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars,"...
Април КСНУМКС, КСНУМКС
Данас, америчка администрација за храну и лекове пружа кратак преглед вести из целе агенције:
Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars,"...
256482
Сигнали
https://www.cnbc.com/2024/05/01/healthy-returns-humira-sales-are-falling-but-abbvie-has-successors.html
Сигнали
ЦНБЦ
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Sales of 's Humira are plummeting as the once-top-selling drug fights competition from cheaper biosimilars in the U.and abroad. . That was clear after AbbVie on Friday reported first-quarter revenue and adjusted profit that topped Wall Street's expectations, partly driven by strength in the drugmaker's immunology business.
256481
Сигнали
https://www.csrwire.com/press_releases/800871-jazz-pharmaceuticals-focuses-taking-actions-positively-impact-planet-earth
Сигнали
Цсрвире
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology.
256471
Сигнали
https://www.forbes.com/sites/joshuacohen/2024/05/03/medicare-says-it-expects-to-spend-35-billion-in-2025-on-alzheimers-drug-leqembi-but-this-is-unlikely/
Сигнали
Форбс
ABINGTON, PA - NOV 7: Nurse Christine Besso, center, helps Robert Williford, 66, left, during his ... [+] first session of receive the newly FDA approved Alzheimer's treatment Leqembi while Williford's wife Cynthia Byron-Williford, 59, right, watches at Abington Neurological Associates in...
256473
Сигнали
https://www.jmir.org/2024/1/e48572/
Сигнали
Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study
Јмир
Introduction In recent years, the issue of drug toxicity has emerged as a serious concern in the fields of clinical medicine, pharmacology, and sociology. As a result, drug regulatory agencies worldwide are making continuous efforts to monitor marketed drugs and assess their potential risks in...
256472
Сигнали
https://www.finsmes.com/2024/05/latus-raises-54m-in-series-a-financing.html
Сигнали
Финсмес
Latus Bio, a Philadelphia, PA-based biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), raised $54M in Series A funding.
The round was led by 8VC and DCVC Bio.
To date, Samsung Life Science Fund (created by Samsung C&T, Samsung...
The round was led by 8VC and DCVC Bio.
To date, Samsung Life Science Fund (created by Samsung C&T, Samsung...
256479
Сигнали
https://www.healio.com/news/dermatology/20240501/eli-lillys-firstquarter-financial-results-highlight-resubmission-of-bla-for-lebrikizumab
Сигнали
Хеалио
Може 01, 2024
КСНУМКС мин прочитао
Eli Lilly's first-quarter financial results highlight resubmission of BLA for lebrikizumab
Додајте тему у обавештења путем е-поште
Додато у обавештења е-поштом
Нисмо могли да обрадимо ваш захтев. Покушајте поново касније. Ако ти...
КСНУМКС мин прочитао
Eli Lilly's first-quarter financial results highlight resubmission of BLA for lebrikizumab
Додајте тему у обавештења путем е-поште
Додато у обавештења е-поштом
Нисмо могли да обрадимо ваш захтев. Покушајте поново касније. Ако ти...
256470
Сигнали
https://www.startribune.com/thousands-believe-covid-vaccines-harmed-them-is-anyone-listening/600363571/
Сигнали
Стартрибуне
У року од неколико минута након што је добила вакцину Јохнсон & Јохнсон ЦОВИД-19, Мишел Цимерман осетила је бол који је јурио од леве руке до уха и до врхова прстију. За неколико дана, била је неподношљиво осетљива на светлост и борила се да запамти једноставне чињенице. Имала је 37 година, докторирала неуронауке, а до тада је могла да вози бицикл 20 миља, држи час плеса и држи предавање о вештачкој интелигенцији, све у истом дану.
256480
Сигнали
https://www.pharmaceutical-technology.com/news/enlaza-series-a-funding/
Сигнали
Фармацеутска-технологија
Enlaza Therapeutics has raised $100m in a Series A financing round headed by the Life Sciences group of JP Morgan Asset Management's private capital division.
The funding round also saw contributions from a mix of existing and new investors, including Frazier Life Sciences, Lightspeed Venture...
The funding round also saw contributions from a mix of existing and new investors, including Frazier Life Sciences, Lightspeed Venture...